Incidence of shock and quality of life in young patients with implantable cardioverter-defibrillator;Incidência de choques e qualidade de vida em jovens com cardioversor-desfibrilador implantável

Arquivos Brasileiros de Cardiologia

Volumn 88, Issue 3, 2007, Pages

  Costa, Roberto ^a,b   Da Silva, Kátia Regina ^a   Mendonça, Rodrigo Castro ^a   Nishioka, Silvana Angelina D'Ório ^a   Siqueira, Sérgio De Freitas ^a   Tamaki, Wagner Tetsuji ^a   Crevelari, Elizabeth Sartori ^a   Moreira, Luiz Felipe Pinho ^a   Martinelli Filho, Martino ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

Adolescent; Defibrillators, implantable; Quality of life

Indexed keywords

ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DEFIBRILLATOR; ELECTRIC SHOCK; EMOTION; FEAR; FEMALE; FOLLOW UP; HEART ARREST; HEART DEATH; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; INTERVIEW; KAPLAN MEIER METHOD; MALE; MENTAL HEALTH; POLYMORPHIC VENTRICULAR TACHYCARDIA; PROPHYLAXIS; QUALITY OF LIFE; QUALITY OF LIFE INDEX; QUESTIONNAIRE; SUPRAVENTRICULAR TACHYCARDIA; TELEMETRY; TREATMENT INDICATION; CARDIOVERSION; HEART ARRHYTHMIA; PRESCHOOL CHILD; STATISTICS; SUDDEN DEATH;

ADOLESCENT; ADULT; ARRHYTHMIAS, CARDIAC; CHILD; CHILD, PRESCHOOL; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; FEMALE; HEART ARREST; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; QUALITY OF LIFE; QUESTIONNAIRES; TACHYCARDIA, SUPRAVENTRICULAR;

EID: 34249788438     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. The Antiarrhytmic Versus Implantable Defibrillator (AVID) investigators. A comparison of antiarrhytmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med. 1997; 337: 1576-83.
2. Kuck KH, Cappato R, Siebels J, Rüppel R, For the CASH Investigators. Randomized comparison of antiarrhythmic drug therapy with Implantable defibrillators in patients resuscitated from cardiac arrest (CASH). Circulation. 2000; 102: 748-57.
3. Connolly S, Gent M, Roberts R, Dorian P, Roy D, Sheldon RS, et al. for the CIDS Investigators. Canadian Implantable Defibrillator Study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation. 2000; 101: 1297-302.
4. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med. 1996; 335: 1933-40.
5. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EM, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med. 1999; 341: 1882-90.
6. Gregoratos G, Abrams J, Epstein AE, Freedman RA, Hayes DL, Hlatky MA, et al. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2002; 106: 2145-61.
7. Stefanelli CB, Bradley DJ, Lerroy S, Dick II M, Serwer GA, Fischbach P. Implantable cardioverter defibrillator therapy for life-treatening arrhythmias in young patients. J Interv Cardiac Electrophysiol. 2002; 6: 235-44.
8. Korte T, Köditz H, Niehaus M, Paul T, Tebbenjohanns J. High incidence of appropriate and inappropriate ICD therapies in children and adolescents with implantable cardioverter defibrillator. Pacing Clin Electrophysiol. 2004; 27: 924-932.
9. Hamilton RM, Dorian P, Gow RM, Williams WG. Five-year experience with implantable defibrillators in children. Am J Cardiol. 1996; 77: 524-6.
10. Gradaus R, Wollmann C, Köbe J, Hammel D, Kotthoff S, Block M, et al. Potencial benefit from implantable cardioverter-defibrillator therapy in children and young adolescents. Heart. 2004; 90: 328-9.
11. Ten Harkel ADJ, Blom NA, Reimer AG, Tukkie R, Sreeram N, Bink-Boelkens MTE. Implantable cardioverter defibrillator implantation in children in The Netherlands. Eur J Pediatr. 2005; 164: 436-41.
12. Cicconelli RM, Ferraz MB, Santos W, Meinão I, Quaresma MR. Tradução para a língua portuguesa e validação do questionário genérico de avaliação de qualidade de vida. SF-36 (Brasil SF-36). Rev Bras Reumatol. 1999; 39 (3): 143-50.
13. Heyland DK, Hopman W, Coo H, Tranmer J, McColl MA. Long-term health-related quality of life in survivors of sepsis. Short Form 36: A valid and reliable measure of health-related quality of life. Crit Care Med. 2000; 28 (11): 3599-605.
14. Wilson WR, Greer GE, Grubb BP. Implantable cardioverter-defibrillators in children: a single-institutional experience. Ann Thorac Surg. 1998; 65: 775-8.
15. Groh WJ, Silka MJ, Oliver RP, Halperin BD, McAnulty JH, Kron J. Use of implantable cardioverter-defibrillators in the congenital long QT syndrome. Am J Cardiol. 1996; 78: 703-6.
16. Kron J, Oliver RP, Norsted S, Silka MJ. The automatic implantable cardioverter-defibrillator in young patients. J Am Coll Cardiol. 1990; 16: 896-902.
17. Kral MA, Spotnitz HM, Hordof A, Bigger Jr JT, Steinberg JS, Livelli FD. Automatic implantable cardioverter defibrillator implantation for malignant ventricular arrhythmias associated with congenital heart disease. Am J Cardiol. 1989; 63: 118-9.
18. Weber M, Block M, Brunn J, Bansch D, Bocker D, Hammel D, et al. Inappropriate ICD-therapies: incidence, causes, risk factors and prevention. Z Kardiol.1996; 85: 809-19.
19. Hook BG, Marchlinski FE. Value of ventricular electrogram in the diagnosis of arrhythmias precipitating electrical device therapy. J Am Coll Cardiol. 1991; 17: 985-90.
20. Nunain SO, Roelke M, Trouton T, Oswald S, Kim YH, Sosa-Suarez G, et al. Limitations and late complications of third generation automatic cardioverter-defibrillators. Circulation. 1995; 91: 2204-13.
21. Love BA, Barrett KS, Alexander ME, Bevilacqua LM, Epstein MR, Triedman JK, et al. Supraventricular arrhythmias in children and young adults with implantable cardioverter defibrillators. J Cardiovasc Electrophysiol. 2001; 12: 1097-101.
22. Sears SF, Conti JB. Quality of life and psychological functioning of ICD patients. Heart. 2002; 87: 488-93.
23. DeMaso DR, Lauretti A, Spieth L, Van Der Feen JR, Jay KS, Gauvreau K, et al. Psychological factors and quality of life in children and adolescents with implantable cardioverter-defibrillators. Am J Cardiol. 2004; 93: 582-7.
24. Schron EB, Exner DV, Yao Q, Jenkins LS, Steinberg JS, Cook JR, et al. Quality of life in the antiarrhythmics versus implantable defibrillators trial: impact of therapy and influence of adverse symptoms and defibrillator shocks. Circulation. 2002; 105: 589-94.
25. Irvine J, Dorian P, Baker B, O'Brien BJ, Roberts R, Gent M, et al. Quality of life in the Canadian implantable defibrillator study (CIDS). Am Heart J. 2002; 144: 282-9.
26. Cortina JM. What is coefficient alpha? An examination of theory and applications. J Appl Psychol. 1993; 78: 98-104.
27. Doward LC, Meads DM, Thorsen MD. Requirements for quality of life instruments in clinical research. Value Health. 2004; 7(Suppl 1): S13-S16.
28. Burgess ES, Quigley JF, Moran G, Sutton FJ, Goodman M. Predictors of psychosocial adjustment in patients with implantable cardioverter defibrillators. Pacing Clin Electrophysiol. 1997; 20: 1790-5.
29. Sears SF, Todaro JF, Urizar G, Lewis TS, Sotile W, Conti JB. Assessing the psychosocial impact of the ICD: a national survey of implantable cardioverter defibrillator health care providers. Pacing Clin Electrophysiol. 2000; 23: 939-45.
30. Dubin AM, Batsford WP, Lewis RJ, Rosenfeld LE. Quality-of-life in patients receiving implantable cardioverter-defibrillators at or before age 40. Pacing Clin Electrophysiol. 1996; 19: 1555-9.